Two-stage reconstruction of infected hip joints.
Two-stage reconstruction using an antibiotic-loaded cement spacer is the preferred treatment of deep infection after total hip arthroplasty (THA). We evaluated the results of this technique for the treatment of primary hip infections. Nine consecutive patients with infected hip joints were treated using this technique. The average duration of follow-up was 42 months. Debridement and insertion of an antibiotic-loaded cement spacer was performed in the first stage. After eradication of infection, it was converted to THA in the second stage. Of the 9 hips, 8 were successfully converted to THA after an average of 23 weeks. One patient required spacer reinsertion, and another experienced reinfection after THA. Average Harris hip score improved from 38.37 before surgery to 57.62 between the 2 stages to 97.83 at final follow-up. Two-stage reconstruction using an antibiotic-loaded cement spacer was found to give satisfactory results for the treatment of hip infections with various etiologies.
Center for Joint Disease, Chonnam National University Hwasun Hospital, 160 Ilsim-Ri, Hwasun-Eup, Hwasun-Gun, Jeonnam 519-809, Korea.
Sanket R
SR
Diwanji
Il Kyu
IK
Kong
Young Hoon
YH
Park
Sang Gwon
SG
Cho
Eun Kyoo
EK
Song
Taek Rim
TR
Yoon
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D019644:Arthroplasty, Replacement, Hip / Q000295:instrumentation / Q000379:methods*; D001843:Bone Cements / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D003646:Debridement / Q000379:methods*; D005260:Female; D005500:Follow-Up Studies; D006621:Hip Joint / Q000187:drug effects / Q000382:microbiology / Q000601:surgery; D006622:Hip Prosthesis / Q000009:adverse effects / Q000382:microbiology; D006801:Humans; D008297:Male; D008875:Middle Aged; D016459:Prosthesis-Related Infections / Q000382:microbiology / Q000628:therapy*; D012086:Reoperation; D013203:Staphylococcal Infections / Q000188:drug therapy / Q000209:etiology; D016896:Treatment Outcome
D000900:Anti-Bacterial Agents; D001843:Bone Cements